Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Orchid Chemicals & Pharma receives closure notice for GMP issues
Cephalosporin API manufacturing plant manufactures a range of oral and sterile Cephalosporin APIs and caters to the developed markets like US, Europe and Japan. The closure notice has
Cephalosporin API manufacturing plant manufactures a range of oral and sterile Cephalosporin APIs and caters to the developed markets like US, Europe and Japan. The closure notice has
The new hub – India Distribution Center (IDC) – will ramp up the availability, timely delivery and quality of products to customers in the region. Life Technologies operates
The company will conduct the test runs by the end of this month to investigate whether the plant is maintaining GMP. Additionally, the company will also verify its
APP Pharma is a subsidiary of Fresenius Kabi Pharmaceuticals. Clonidine Hydrochloride injection is used in conjunction with opiates to treat severe pain in cancer patients which is not
The trial compared experimental drug alemtuzumab with approved multiple sclerosis (MS) drug Rebif which showed 55% reduction in relapse rate in 2 annual cycles of alemtuzumab treatment as
Dermik’s product portfolio consists therapeutic and aesthetic dermatology brands like: BenzaClin for the treatment of acne, Carac for the treatment of keratoses and Sculptra, a facial injectable for
Rigosertib is a patent protected multi-kinase inhibitor of critical pathways important in the growth and proliferation of cancer cells. As per the terms of the agreement, SymBio will
Under the agreement, the researchers of ETH Zurich’s Institute of Molecular Systems Biology will use IBM’s SmartCloud Enterprise and data management solutions of CloudBroker for identifying around 250
The double-blind, randomized and placebo-controlled trial will recruit around 48 healthy subjects and 20 HCV genotype 1 treatment naive patients in the US. Achillion president and CEO Michael
China-based Chongqing Lummy is engaged in research, development, manufacture and sale of anti-infective, oncology and nutritional parenteral products. With this agreement, Sagent intends to strengthen its presence in